Heimdall Insights

Global Lymphoma Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: July 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Lymphoma Therapeutics Market was valued at $20.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.4% CAGR, to an estimated market size of $30.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global lymphoma therapeutics market encompasses the development, manufacturing, and distribution of pharmaceutical treatments for Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL). The scope includes various treatment modalities such as immunotherapy, targeted therapy, chemotherapy, radiation therapy, and advanced CAR-T cell therapies, while excluding general supportive care and non-oncological lymphatic treatments.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Lymphoma Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Non-Hodgkin Lymphoma (NHL)
  • Hodgkin Lymphoma (HL)